Polymorphisms in serine hydroxymethyltransferase 1 and methylenetetrahydrofolate reductase interact to increase cardiovascular disease risk in humans.

The enzymes serine hydroxymethyltransferase 1 (gene name SHMT1) and methylenetetrahydrofolate reductase (gene name MTHFR) regulate key reactions in folate-mediated one-carbon metabolism. Common genetic variants with the potential to influence disease risk exist in both genes. A prior report from the Normative Aging Study indicated no association of the SHMT1 rs1979277 SNP with cardiovascular disease (CVD), but a strong gene-gene interaction was detected with MTHFR rs1801133. We investigated the effect of the SHMT1 rs1979277 SNP and the SHMT1 rs1979277-MTHFR rs1801133 interaction in 2 epidemiologic cohort studies. In the Nurses' Health Study (NHS), the MTHFR rs1801133 variant genotypes were associated with an increased CVD risk and there was an interaction between SHMT1 and MTHFR such that the association of the MTHFR rs1801133 CT genotype (vs. CC; the TT genotype could not be evaluated) was stronger in the presence of the SHMT1 rs1979277 TT genotype (OR = 4.34, 95% CI = 1.2, 16.2; P = 0.049). In the Health Professionals Follow-Up Study, the MTHFR rs1801133 genotype was not associated with CVD risk, nor was there an interaction with SHMT1 rs1979277. The association of genetic variation in the SHMT1 gene, alone and in interaction with MTHFR, in relation to CVD risk is relatively understudied at the population level and results in the NHS confirmed a past report of gene-gene interaction, which is consistent with mechanisms suggested by basic science studies.

[1]  P. Stover,et al.  SHMT1 and SHMT2 Are Functionally Redundant in Nuclear De novo Thymidylate Biosynthesis , 2009, PloS one.

[2]  A. Patiño-García,et al.  Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression. , 2009, The Journal of pediatrics.

[3]  P. Stover,et al.  Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a minireview. , 2009, Birth defects research. Part A, Clinical and molecular teratology.

[4]  W. Tissing,et al.  Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. , 2009, Blood.

[5]  P. Stover,et al.  Cytoplasmic Serine Hydroxymethyltransferase Regulates the Metabolic Partitioning of Methylenetetrahydrofolate but Is Not Essential in Mice* , 2008, Journal of Biological Chemistry.

[6]  B. Giusti,et al.  Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysm , 2008, Journal of Medical Genetics.

[7]  P. Vokonas,et al.  Cardiac Autonomic Dysfunction: Effects From Particulate Air Pollution and Protection by Dietary Methyl Nutrients and Metabolic Polymorphisms , 2008, Circulation.

[8]  M. Koury,et al.  S-Adenosylhomocysteine: a better indicator of vascular disease than homocysteine? , 2007, The American journal of clinical nutrition.

[9]  N. Rothman,et al.  One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia , 2007, Human Genetics.

[10]  A. Neugut,et al.  Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. , 2007, Carcinogenesis.

[11]  P. Stover,et al.  Evidence for Small Ubiquitin-like Modifier-dependent Nuclear Import of the Thymidylate Biosynthesis Pathway* , 2007, Journal of Biological Chemistry.

[12]  S. Chanock,et al.  Genetic polymorphisms in the one‐carbon metabolism pathway and breast cancer risk: A population‐based case–control study and meta‐analyses , 2007, International journal of cancer.

[13]  N. Malats,et al.  Polymorphisms in one‐carbon metabolism and trans‐sulfuration pathway genes and susceptibility to bladder cancer , 2007, International journal of cancer.

[14]  E. Kampman,et al.  Dietary intake of B-vitamins, polymorphisms in thymidylate synthase and serine hydroxymethyltransferase 1, and colorectal adenoma risk: a Dutch case-control study. , 2007, Cancer letters.

[15]  N. Rothman,et al.  Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. , 2007, Blood.

[16]  E-P Chiang,et al.  Folate restriction and methylenetetrahydrofolate reductase 677T polymorphism decreases adoMet synthesis via folate-dependent remethylation in human-transformed lymphoblasts , 2007, Leukemia.

[17]  W. Willett,et al.  Nonsynonymous Polymorphisms in Genes in the One-Carbon Metabolism Pathway and Associations with Colorectal Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[18]  G. Salles,et al.  Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas. , 2006, Blood.

[19]  J. Manson,et al.  Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of coronary heart disease among US women. , 2006, Atherosclerosis.

[20]  F. Coppedè,et al.  Risk of Non–Hodgkin Lymphoma Associated with Polymorphisms in Folate-Metabolizing Genes , 2005, Cancer Epidemiology Biomarkers & Prevention.

[21]  S. Lewis,et al.  Meta-analysis of MTHFR 677C→ T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? , 2005, BMJ : British Medical Journal.

[22]  R. Strawderman,et al.  Polymorphisms in cytoplasmic serine hydroxymethyltransferase and methylenetetrahydrofolate reductase affect the risk of cardiovascular disease in men. , 2005, The Journal of nutrition.

[23]  M. Spitz,et al.  Polymorphisms and haplotypes of serine hydroxymethyltransferase and risk of squamous cell carcinoma of the head and neck: a case–control analysis , 2005, Pharmacogenetics and genomics.

[24]  J. Manson,et al.  Homocysteine as a risk factor for coronary heart diseases and its association with inflammatory biomarkers, lipids and dietary factors. , 2004, Atherosclerosis.

[25]  Alan Hubbard,et al.  Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. , 2004, Blood.

[26]  D. Hunter,et al.  Polymorphisms in the one‐carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study , 2004, International journal of cancer.

[27]  Nader Rifai,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[28]  D. Wald,et al.  Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis , 2002, BMJ : British Medical Journal.

[29]  Petra Verhoef,et al.  MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis. , 2002, JAMA.

[30]  Katherine L. Herbig,et al.  Cytoplasmic Serine Hydroxymethyltransferase Mediates Competition between Folate-dependent Deoxyribonucleotide andS-Adenosylmethionine Biosyntheses* , 2002, The Journal of Biological Chemistry.

[31]  G. Morgan,et al.  Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. , 2002, Blood.

[32]  Krista A. Zanetti,et al.  Molecular cloning, characterization and alternative splicing of the human cytoplasmic serine hydroxymethyltransferase gene. , 1998, Gene.

[33]  S. Hankinson,et al.  No association between cSHMT genotypes and the risk of breast cancer in the Nurses' Health Study , 2010, European Journal of Clinical Nutrition.

[34]  P. Stover,et al.  Folate-mediated one-carbon metabolism. , 2008, Vitamins and hormones.

[35]  A. Smith,et al.  Facts and recommendations about total homocysteine determinations: an expert opinion. , 2004, Clinical chemistry.

[36]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.